Combining TIL with Small Molecule Inhibitors to Enhance T – Cell Expansion & Phenotypes

Time: 2:00 pm
day: Day One


• Expanding the scope of indications to include gynaecological malignancies by combining with small molecule inhibitors

• Applying targeted protein modulation to adoptive cell therapy

• Inhibiting CBL-B to stimulate IL-2 secretion, reduce T cell exhaustion and improve clinical outcomes